Andrew C. Weiss
Investor Relations Contact chez IDORSIA LTD
Postes actifs de Andrew C. Weiss
Sociétés | Poste | Début | Fin |
---|---|---|---|
IDORSIA LTD | Investor Relations Contact | 01/06/2017 | - |
Public Communications Contact | 01/06/2017 | - |
Historique de carrière de Andrew C. Weiss
Anciens postes connus de Andrew C. Weiss
Sociétés | Poste | Début | Fin |
---|---|---|---|
ACTELION | Investor Relations Contact | 05/05/2014 | 01/01/2017 |
Public Communications Contact | 05/05/2014 | 01/01/2017 | |
Bank Sarasin & Cie AG (Broker) | Analyst-Equity | - | 01/05/2007 |
Julius Baer Holding AG | Corporate Officer/Principal | 01/01/2000 | 01/01/2005 |
Bank Vontobel AG (Research Firm) | Analyst-Equity | - | - |
Formation de Andrew C. Weiss
University of Zurich | Graduate Degree |
Statistiques
Internationale
Suisse | 7 |
Opérationnelle
Analyst-Equity | 2 |
Investor Relations Contact | 2 |
Public Communications Contact | 2 |
Sectorielle
Finance | 4 |
Health Technology | 3 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
IDORSIA LTD | Health Technology |
Entreprise privées | 4 |
---|---|
Actelion Ltd.
Actelion Ltd. Pharmaceuticals: MajorHealth Technology Actelion Ltd. develops, produces and markets pharmaceutical drugs. The firm engages in research, development, manufacturing, and distribution of pharmaceutical, biological, and diagnostic products. The company was founded by Jean-Paul Clozel, Martine Clozel, Walter Fischli, André J. Müller and Thomas Widmann on December 30, 1999 and is headquartered in Allschwil, Switzerland. | Health Technology |
Bank Vontobel AG (Research Firm) | Finance |
Bank Sarasin & Cie AG (Broker) | Finance |
Julius Baer Holding AG | Finance |
- Bourse
- Insiders
- Andrew C. Weiss
- Expérience